You are here
Samsung's drug-making unit soars on market debut
SHARES in Samsung's drug-making unit soared almost six per cent on their market debut on Thursday, after one of South Korea's biggest ever initial public offerings that raised nearly US$2 billion.
Samsung Biologics, a contract manufacturer of biotech drugs for global
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org